SEC Form 4 · accession 0001104659-19-003229
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yakob Liawatidewi
Officer — SVP Corp Admin Center
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2019 | M | 3,000 | $10.48 | A | 40,463 | D | |
| Common Stock | Jan 22, 2019 | S | 3,000 | $22.35 | D | 37,463 | D | |
| Common Stock | Jan 23, 2019 | M | 4,000 | $10.48 | A | 41,463 | D | |
| Common Stock | Jan 23, 2019 | S | 4,000 | $22.65 | D | 37,463 | D | |
| Common StockF2 | holding | — | — | — | 6,369 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $10.48 | Jan 22, 2019 | M | 3,000 | D | — | Nov 7, 2022 | Common Stock | 3,000 | 13,817 | D |
| Employee Stock Option (right to buy)F3 | $10.48 | Jan 23, 2019 | M | 4,000 | D | — | Nov 7, 2022 | Common Stock | 4,000 | 9,817 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018.
- F2The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
- F3Shares subject to the option are fully vested and immediately exercisable.